← Eichor
Study identifier: NCT07434050 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Condition: OSA - Obstructive Sleep Apnea · Obesity  ·  Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.

PhasePhase 3
Planned participants140
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Rui Jin HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07434050